A hospital in India has signed a memorandum of understanding with the Indian Council of Medical Research (ICMR) to carry out a study on the safety and efficacy of convalescent plasma to limit coronavirus-associated complications , reported Business Standard.
Plasma collected from a recovered COVID-19 patient was administered to a patient at the medical facility for the first time on Monday, according to Ahmedabad municipal commissioner Vijay Nehra.
The Sardar Vallabhbhai Patel Hospital will now carry out a Phase II randomised trial to assess the safety and efficacy of convalescent plasma to limit COVID-19-associated complications in moderate disease, he said.
The ICMR recently said it has received 99 applications from institutes willing to take part in the study.
To read more NewsPoints articles, click here.